Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 2
2011 3
2012 5
2013 2
2017 2
2018 2
2019 5
2020 15
2021 8
2022 11
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM; REDUCE-IT Investigators. Bhatt DL, et al. N Engl J Med. 2019 Jan 3;380(1):11-22. doi: 10.1056/NEJMoa1812792. Epub 2018 Nov 10. N Engl J Med. 2019. PMID: 30415628 Clinical Trial.
Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial.
Budoff MJ, Bhatt DL, Kinninger A, Lakshmanan S, Muhlestein JB, Le VT, May HT, Shaikh K, Shekar C, Roy SK, Tayek J, Nelson JR. Budoff MJ, et al. Among authors: roy sk. Eur Heart J. 2020 Oct 21;41(40):3925-3932. doi: 10.1093/eurheartj/ehaa652. Eur Heart J. 2020. PMID: 32860032 Free PMC article. Clinical Trial.
Anti-inflammatory Therapeutics and Coronary Artery Disease.
Eghtedari B, Roy SK, Budoff MJ. Eghtedari B, et al. Among authors: roy sk. Cardiol Rev. 2023 Mar-Apr 01;31(2):80-86. doi: 10.1097/CRD.0000000000000428. Epub 2021 Oct 20. Cardiol Rev. 2023. PMID: 35471811 Review.
The Role of Cardiac Computed Tomography in Heart Failure.
Kitchin SS, Manubolu VS, Roy SK, Budoff MJ. Kitchin SS, et al. Among authors: roy sk. Curr Heart Fail Rep. 2022 Aug;19(4):213-222. doi: 10.1007/s11897-022-00553-2. Epub 2022 May 19. Curr Heart Fail Rep. 2022. PMID: 35588344 Review.
Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG.
Verma S, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Dhingra NK, Ketchum SB, Juliano RA, Jiao L, Doyle RT Jr, Granowitz C, Gibson CM, Pinto D, Giugliano RP, Budoff MJ, Mason RP, Tardif JC, Ballantyne CM; REDUCE-IT Investigators. Verma S, et al. Circulation. 2021 Dec 7;144(23):1845-1855. doi: 10.1161/CIRCULATIONAHA.121.056290. Epub 2021 Oct 28. Circulation. 2021. PMID: 34710343 Free article. Clinical Trial.
Quantitative imaging biomarkers of coronary plaque morphology: insights from EVAPORATE.
Buckler AJ, Doros G, Kinninger A, Lakshmanan S, Le VT, Libby P, May HT, Muhlestein JB, Nelson JR, Nicolaou A, Roy SK, Shaikh K, Shekar C, Tayek JA, Zheng L, Bhatt DL, Budoff MJ. Buckler AJ, et al. Among authors: roy sk. Front Cardiovasc Med. 2023 Aug 3;10:1204071. doi: 10.3389/fcvm.2023.1204071. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37600044 Free PMC article.
57 results